Histone deacetylase inhibition sensitizes osteosarcoma to heavy ion radiotherapy

被引:0
作者
Claudia Blattmann
Susanne Oertel
Markus Thiemann
Anne Dittmar
Eva Roth
Andreas E. Kulozik
Volker Ehemann
Wilko Weichert
Peter E. Huber
Albrecht Stenzinger
Jürgen Debus
机构
[1] University of Heidelberg,Department of Radiation Oncology
[2] University Children’s,Department of Pediatric Oncology, Hematology and Immunology
[3] Hospital of Heidelberg,Institute of Pathology
[4] University of Heidelberg,Department of Radiation Oncology
[5] German Cancer Research Center,National Center for Tumor Diseases (NCT)
[6] German Cancer Consortium (DKTK),undefined
[7] University of Heidelberg,undefined
[8] Pädiatrie 5,undefined
[9] Olgahospital,undefined
来源
Radiation Oncology | / 10卷
关键词
Osteosarcoma; Carbon ion radiotherapy; Histone deacetylase inhibition; Suberoylanilide hydroxamic acid; Radiosensitization; Mouse model;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 158 条
[1]  
Schardt D(2010)Heavy-ion tumor therapy: Physical and radio-biological benefits Rev Mod Phys 82 383-51
[2]  
Elsässer T(2009)Long-term outcome after polychemotherapy and intensive local radiation therapy of high-grade osteosarcoma Eur J Cancer 45 2447-31
[3]  
Schulz-Ertner D(2010)Non-randomized therapy trial to determine the safety and efficacy of heavy ion therapy in patients with non-resectable osteosarcomas BMC Cancer 10 96-63
[4]  
Hundsdoerfer P(2012)Carbon ion radiotherapy for localized primary sarcoma of the extremities: results of a phase I/II trial. Working group for the bone and soft tissue sarcomas Radiother Oncol 105 226-94
[5]  
Albrecht M(2012)Impact of carbon ion radiotherapy for unresectable osteosarcoma of the trunk. Working group for bone and soft tissue sarcomas Cancer 118 4555-8
[6]  
Rühl U(2012)Treatment of pediatric patients and young adults with particle therapy at the Heidelberg Ion Therapy Center (HIT): establishment of workflow and initial clinical data Radiat Oncol 7 170-52
[7]  
Fengler R(2012)Sensitization of tumor cells by targeting histone deacetylases Biochem Pharmacol 83 987-22
[8]  
Kulozik AE(2007)In vivo efficacy of a novel histone deacetylase inhibitor in combination with radiation for the treatment of gliomas Neuro Oncol 9 82-9
[9]  
Henze G(2009)Radiosensitization by SAHA in experimental colorectal carcinoma models - in vivo effects and relevance of histone acetylation status Int J Radiat Oncol Biol Phys 74 546-66
[10]  
Blattmann C(2005)Histone deacetylase inhibitors radiosensitize human melanoma by suppressing DNA repair activity Clin Cancer Res 11 4912-45